(Press-News.org) Among men undergoing radiation therapy for prostate cancer, daily use of the erectile dysfunction drug tadalafil, compared with placebo, did not prevent loss of erectile function, according to a study in the April 2 issue of JAMA.
Erectile dysfunction (ED) is a common condition resulting from many causes, including prostate cancer treatment. An estimated 40 percent of men report ED after radiation therapy, and half of all men use erectile aids following this therapy. Tadalafil is used to treat erectile dysfunction after prostate cancer treatment, but its role as a preventive agent has not been determined, according to background information in the article.
Thomas M. Pisansky, M.D., of the Mayo Clinic, Rochester, Minn., and colleagues with the Radiation Therapy Oncology Group, randomly assigned 242 men with prostate cancer to receive tadalafil (5 mg) or placebo daily for 24 weeks starting with radiation therapy (either with external radiotherapy [63 percent] or brachytherapy [37 percent]). The study was conducted at 76 sites in the United States and Canada; participants were recruited between November 2009 and February 2012, with follow-up through March 2013.
Between weeks 28 and 30 after the start of radiation therapy, among evaluable participants, 79 percent who received tadalafil retained erectile function compared with 74 percent who received placebo, an absolute difference of 5 percent. A significant difference between groups was also not observed at 1 year (72 percent vs 71 percent). Tadalafil was not associated with improved overall sexual function or satisfaction, and partners of men assigned tadalafil noted no significant effect on sexual satisfaction.
"These findings do not support the scheduled once-daily use of tadalafil to prevent ED in men undergoing radiotherapy for localized prostate cancer," the authors write.
They add that alternative strategies to prevent ED in this context appear warranted, including different dosing or further refinements of radiation therapy delivery methods.INFORMATION:
(doi:10.1001/jama.2014.2626; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: This trial was conducted by the Radiation Therapy Oncology Group, which was supported by grants from the National Cancer Institute and by Eli Lilly & Co. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.
Medication does not help prevent ED following radiation therapy for prostate cancer
2014-04-01
ELSE PRESS RELEASES FROM THIS DATE:
Outcomes of administering blood transfusions to patients with lower levels of hemoglobin
2014-04-01
Restricting red blood cell (RBC) transfusions among hospitalized patients to those with hemoglobin (the iron-containing protein in RBCs) measures below a certain level is associated with a lower risk of health care-associated infections, according to a study in the April 2 issue of JAMA.
Efforts to prevent health care-associated infection are among the priorities for the U.S. Department of Health and Human Services. The estimated annual direct medical costs of health care-associated infections to U.S. hospitals ranges from $28 billion to $45 billion, with about 1 in ...
The potential conflict of interest for leaders of AMCs serving on pharmaceutical boards
2014-04-01
About 40 percent of pharmaceutical company boards of directors examined had at least one member who held a leadership position at an academic medical center, with annual compensation for these positions averaging approximately $300,000, according to a study in the April 2 issue of JAMA.
"Financial relationships between the pharmaceutical industry and physicians have come under increased scrutiny. Less attention has been paid to relationships between industry and the leadership of academic medical centers (AMCs), who wield considerable influence over research, clinical, ...
Experts question routine mammograms in elderly
2014-04-01
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.
National guidelines recommend that doctors make individualized screening decisions for women 75 and older. But the analysis, published online Tuesday in JAMA (March 31, 2014), concluded that since this age group was not included in mammography ...
Night owls, unlike early birds, tend to be unmarried risk-takers
2014-04-01
Women who are night owls share the same high propensity for risk-taking as men, according to a recent study by a University of Chicago professor.
The research suggests that sleep patterns are linked with important character traits and behavior, said study author Dario Maestripieri, professor in Comparative Human Development. Night owls—people who tend to stay up late and wake up late in the morning—are different in many important ways from early risers, he found.
"Night owls, both males and females, are more likely to be single or in short-term romantic relationships ...
Like hand-washing, blood transfusions linked to infections
2014-04-01
Blood transfusions are among the most common treatments for hospitalized patients nationwide, but doing them less often reduces infection rates by nearly 20 percent, according to a study in the Journal of the American Medical Association co-authored by Neil Blumberg, M.D., professor at the University of Rochester School of Medicine and Dentistry.
As director of transfusion medicine and the blood bank at UR Medicine, Blumberg for more than 25 years has been investigating how to make blood transfusions safer. The JAMA study is the first to show conclusively, through a study ...
A protein could be a key weapon in the battle of the bulge
2014-04-01
Bethesda, MD (April 1, 2014)— More than one-third of people in the US are obese. Obesity and its related health problems—including high blood pressure, high cholesterol, diabetes, insulin resistance, and belly fat—affect so many, yet effective treatments are very few. In a new study, Simon Musyoka Mwangi and colleagues tested whether higher levels of a certain protein help fight the weight gain and health problems caused by eating the wrong foods.
Glial cell line-derived neurotrophic factor—or GDNF for short—is a protein integral to keeping the body's systems in balance ...
Adult tonsillectomy complications and health care expenses
2014-04-01
A study released today of 36,210 adult tonsillectomy patients finds that 20 percent will have a complication, offering valuable new insights to a decades long discussion. The study, featured in the April 2014 issue of Otolaryngology—Head and Neck Surgery, examines the prevalence of complications in adult tonsillectomies and the impact on health care expenditures.
"Researchers have been examining variation in tonsillectomy for years," explained corresponding author, Dennis Scanlon, PhD. "Yet most research has been documented in pediatric populations. Much less is known ...
Deforestation of sandy soils a greater climate threat
2014-04-01
Deforestation may have far greater consequences for climate change in some soils than in others, according to new research led by Yale University scientists — a finding that could provide critical insights into which ecosystems must be managed with extra care because they are vulnerable to biodiversity loss and which ecosystems are more resilient to widespread tree removal.
In a comprehensive analysis of soil collected from 11 distinct U.S. regions, from Hawaii to northern Alaska, researchers found that the extent to which deforestation disturbs underground microbial ...
Researchers identify similarities between HIV/AIDS and opioid addiction epidemics
2014-04-01
(PROVIDENCE, R.I.) – There are important parallels between the early years of the HIV/AIDS epidemic and the current epidemic of opioid addiction - ones that could trigger a significant shift in opioid addiction prevention, diagnosis and treatment.
These are the findings of a comparative review of HIV/AIDS and addiction by researchers Josiah D. Rich, M.D., M.P.H., director of the Center for Prisoner Health and Human Rights, based at The Miriam Hospital; Traci C. Green, Ph.D., MSc, Department of Emergency Medicine at Rhode Island Hospital and assistant professor of Emergency ...
Study reveals animal research bias in experimentation oversight committee membership
2014-04-01
Denver — Committees that are federally mandated to review, approve, and monitor the use of animals in experiments—called Institutional Animal Care and Use Committees (IACUC)—are dominated by animal research interests, according to a study presented today (Wednesday April 2) at the 2014 Public Responsibility in Medicine and Research (PRIM&R) IACUC Conference in Denver.
Using the federal Freedom of Information Act, researchers from People for the Ethical Treatment of Animals (PETA) and the University of California–San Diego School of Medicine obtained the current IACUC ...